New England Research & Management, Inc. Fulgent Genetics, Inc. Transaction History
New England Research & Management, Inc.
- $204 Million
- Q1 2024
Shares
2 transactions
Others Institutions Holding FLGT
# of Institutions
199Shares Held
14.7MCall Options Held
1.16MPut Options Held
92.9K-
Black Rock Inc. New York, NY3.92MShares$76.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.42MShares$27.9 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.35MShares$26.4 Million0.01% of portfolio
-
State Street Corp Boston, MA824KShares$16.2 Million0.0% of portfolio
-
Park West Asset Management LLC Larkspur, CA730KShares$14.3 Million1.15% of portfolio
About Fulgent Genetics, Inc.
- Ticker FLGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 30,265,800
- Market Cap $594M
- Description
- Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...